Neuromodulation Targets for Chronic Abdominal Pain
Part of Neuromodulation for Chronic Abdominal Discomfort Syndrome: Targets, Techniques, and Outcomes
Details
- Date
- Friday, January 22, 2027
- Time
- 11:06 AM – 11:21 AM
- Session type
- Concurrent Session
- Schedule
- See this day
About
Chronic Abdominal Discomfort Syndrome (CADS) represents a newly defined clinical entity characterized by persistent abdominal pain without clear structural pathology yet associated with visceral afferent sensitization and central modulation dysfunction. Neuromodulation - targeting DRG (T11-L2), splanchnic nerves, and celiac plexus pathways -offers a promising therapeutic strategy for select phenotypes. However, standardized patient selection, programming strategies, and long-term durability data remain limited. This session provides a structured, phenotype-based approach to visceral neuromodulation.
Presenters
-
Mark Malinowski, DO
Interventional Pain Physician
OhioHealth Neurological Physicians · Columbus, Ohio
Mark N. Malinowski, DO, DABA, DABPM, FIPP
Dr. Malinowski is an interventional pain physician at OhioHealth in Columbus, Ohio. He graduated from Miami University with a degree in Chemistry and a Master of Science in Neuroscience (neuromuscular physiology). Dr. Malinowski subsequently earned his medical degree from LECOM in Erie, Pennsylvania. He then completed an internship at The Western Pennsylvania Hospital in Pittsburgh, followed by both a residency and fellowship in Anesthesiology and Regional Anesthesiology at Ohio State Wexner Medical Center. After completing his training at Ohio State, he completed his pain fellowship at Texas Tech University Health Sciences Center in Lubbock, Texas, under his mentors, Drs. Gabor Racz, Miles Day, Mark Boswell, and Raphael Justiz. He is board-certified in Anesthesiology and Pain Management by the American Board of Anesthesiology and in Pain Management by the American Board of Pain Medicine. He is also a Fellow of Interventional Pain Practice through the World Institute of Pain. He is currently on the Board of Directors for the North American Neuromodulation Society.